Cargando…
The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota
Background: Chitosan oligosaccharides, with an average molecular weight ≤ 1000 Da (COST), is a natural marine product that has the potential to improve intestinal microflora and resist lipid metabolism disorders. Methods: First, by establishing a mice model of lipid metabolism disorder induced by a...
Autores principales: | You, Huimin, Deng, Xiaoyi, Bai, Yan, He, Jincan, Cao, Hua, Che, Qishi, Guo, Jiao, Su, Zhengquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317995/ https://www.ncbi.nlm.nih.gov/pubmed/35877737 http://dx.doi.org/10.3390/md20070444 |
Ejemplares similares
-
GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes
por: Qiu, Shuting, et al.
Publicado: (2022) -
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity
por: You, Huimin, et al.
Publicado: (2022) -
Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism
por: Li, Feng, et al.
Publicado: (2023) -
Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease
por: Feng, Jiayao, et al.
Publicado: (2022) -
The Microstructure, Antibacterial and Antitumor Activities of Chitosan Oligosaccharides and Derivatives
por: Yu, Dawei, et al.
Publicado: (2022)